Pandey Sandeep, Bhutia Ongkila, Roychoudhury Ajoy, Arora Ankit, Bhatt Krushna
Department of Oral and Maxillofacial Surgery, All India Institute of Medical Sciences, New Delhi, India.
Natl J Maxillofac Surg. 2018 Jan-Jun;9(1):2-7. doi: 10.4103/njms.NJMS_33_16.
Ameloblastic carcinoma is considered to be a rare epithelial malignant neoplasm of odontogenic origin occurring mainly in the mandible. Ameloblastic carcinoma has been a topic of controversy regarding management from past many years. We reviewed 86 cases of mandibular ameloblastic carcinoma from 1981 to 2014, on the basis of the electronic search of peer-reviewed journals in MEDLINE (PubMed) database. Age, sex, tumor size, treatment delivered, recurrence, metastasis, follow-up period, and dead/alive status are tabulated, and the data are analyzed. The mean age was 43.47 years with standard deviation ± 21.09. The age range was between 15 and 91 years, and male to female ratio was 2.18:1. Knowledge gained from the present review would help in establishing the best therapeutic options for ameloblastic carcinoma, and it also encourages the further reporting of ameloblastic carcinoma.
成釉细胞癌被认为是一种罕见的牙源性上皮恶性肿瘤，主要发生在下颌骨。多年来，成釉细胞癌在治疗方面一直是一个有争议的话题。我们通过对MEDLINE（PubMed）数据库中同行评审期刊进行电子检索，回顾了1981年至2014年的86例下颌成釉细胞癌病例。将年龄、性别、肿瘤大小、所接受的治疗、复发、转移、随访期以及死亡/存活状态制成表格，并对数据进行分析。平均年龄为43.47岁，标准差为±21.09。年龄范围在15岁至91岁之间，男女比例为2.18:1。从本综述中获得的知识将有助于确定成釉细胞癌的最佳治疗方案，同时也鼓励进一步报告成釉细胞癌病例。
